Stahmeyer, J., & Eisenbach, C. (2016). Outcomes and costs of treating hepatitis C patients in the era of first generation protease inhibitors: Results from the PAN study. PLOS ONE, 11(7), . https://doi.org/10.1371/journal.pone.0159976
Chicago Style (17th ed.) CitationStahmeyer, Jona, and Christoph Eisenbach. "Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors: Results from the PAN Study." PLOS ONE 11, no. 7 (2016). https://doi.org/10.1371/journal.pone.0159976.
MLA (9th ed.) CitationStahmeyer, Jona, and Christoph Eisenbach. "Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors: Results from the PAN Study." PLOS ONE, vol. 11, no. 7, 2016, https://doi.org/10.1371/journal.pone.0159976.